Caroline Lascoux‐Combes

Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once‐daily for the treatment of HIV‐infected adults (pharmacokinetic substudy of the ANRS 091 trial)^*

Gilles Peytavin, Sophie Pérusat, Caroline Lascoux‐Combes et al. · HIV Medicine · 2004 · 37 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy

J. Pavie, Raphaël Porcher, Carlo Torti et al. · Journal of Antimicrobial Chemotherapy · 2011 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Salvage Therapy with Amprenavir, Lopinavir and Ritonavir 200 Mg/D or 400 Mg/D in HIV-Infected Patients in Virological Failure

G Raguin, Geneviève Chêne, Laurence Morand‐Joubert et al. · Antiviral Therapy · 2004 · 24 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Five-Year Follow up of Once-Daily Therapy with Emtricitabine, Didanosine and Efavirenz (Montana ANRS 091 Trial)

Jean‐Michel Molina, Valérie Journot, André Furco et al. · Antiviral Therapy · 2007 · 14 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +14

Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine

Khaled Alnuaimi, Julie Lavolé, Caroline Lascoux‐Combes et al. · Hepatology · 2017 · 13 citations

Medicine, Immunology, Oncology +16